Global Ankylosing Spondylitis Market Report By Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2022-2030
The global demand for Ankylosing Spondylitis Market is presumed to reach the market size of nearly USD 10.85 BN by 2030 from USD 5.29 BN in 2022 with a CAGR of 9.4% under the study period 2023 - 2030.
Ankylosing spondylitis (AS) is a persistent autoimmune condition that predominantly targets the spine and sacroiliac joints, but it can also impact other joints and organs. It belongs to the category of spondyloarthritis, a cluster of disorders characterized by joint and enthesis inflammation (the locations where ligaments and tendons attach to bones).
Increased awareness of ankylosing spondylitis, improved diagnostic methods, and advancements in treatment options, particularly biologic therapies and disease-modifying drugs, are driving the market. The aging global population contributes to a greater number of individuals at risk of this condition, further increasing demand for ankylosing spondylitis-related healthcare services. Genetic research and emerging markets are expanding the market's reach. Regulatory support, patient-centric care, and digital health solutions are also propelling the ankylosing spondylitis market forward. Ongoing research and clinical trials promise new treatment modalities and therapies, fostering continued innovation in its management.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ankylosing spondylitis. The growth and trends of ankylosing spondylitis industry provide a holistic approach to this study.
This section of the ankylosing spondylitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Ankylosing Spondylitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Ankylosing Spondylitis Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Ankylosing Spondylitis market include AbbVie, Inc., Amgen, Inc., Pfizer, Inc., Novartis AG, Eli Lilly and Company, UCB, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . ANKYLOSING SPONDYLITIS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Drug
3.7.2 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL ANKYLOSING SPONDYLITIS MARKET ANALYSIS BY DRUG
5.1 Overview by Drug
5.2 Historical and Forecast Data
5.3 Analysis by Drug
5.4 Cosentyx Historic and Forecast Sales by Regions
5.5 Humira Historic and Forecast Sales by Regions
5.6 Simponi Historic and Forecast Sales by Regions
5.7 Remicade Historic and Forecast Sales by Regions
5.8 Enbrel Historic and Forecast Sales by Regions
5.9 Cimzia Historic and Forecast Sales by Regions
5.10. Others Historic and Forecast Sales by Regions
6 . GLOBAL ANKYLOSING SPONDYLITIS MARKET ANALYSIS BY GEOGRAPHY
6.1. Regional Outlook
6.3. North America Sales Analysis
6.3.1. Overview, Historic and Forecast Data Sales Analysis
6.3.2. North America By Segment Sales Analysis
Frequently Asked Questions (FAQs) about this Report
The Global Ankylosing Spondylitis Market was valued at USD 5.29 BN in 2022.
The worldwide Ankylosing Spondylitis Market is estimated to grow at a CAGR of around 9.4% from 2023 to 2030.
North America accounts for the largest share of the Global Ankylosing Spondylitis Market.
The Global Ankylosing Spondylitis Market is segmented by Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia, Others).
The leading players in the Global Ankylosing Spondylitis Market are AbbVie Inc., Amgen Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, UCB Inc.